US FDA declines to approve Orexo's opioid overdose drug

Orexo AB

16/07/2024 21:10

July 16 (Reuters) - The U.S. Food and Drug
Administration has declined to approve Orexo AB's  ORX.ST 
high-dose prescription drug for opioid overdose, the company
said on Tuesday.

 (Reporting by Vallari Srivastava, Sriparna Roy and Unnamalai L
in Bengaluru; Editing by Tasim Zahid)
 ((Sriparna.Roy@thomsonreuters.com;))